Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 21.2% during trading on Friday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Trading Up 21.2 %
The business’s 50-day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.07. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a market capitalization of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Use the MarketBeat Stock Screener
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to buy stock: A step-by-step guide for beginners
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
